Work hard and gain strength! Beike Biotechnology was successfully selected into the “Shenzhen Famous Brands” list!

On January 21, 2021, at the “Shenzhen Famous Brand” review meeting held by the Shenzhen Federation of Industry, baseline;”>Shenzhen Beike Biotechnology Co., Ltd. stood out from many brands and won the honor of “Shenzhen Famous Brand” due to its high market share, high integrity and high brand awareness, and successfully completed the announcement on January 28!

The “Shenzhen Famous Brand” cultivation and evaluation activity is an activity to promote enterprises to build brands and create famous brands in April 2003. The municipal government issued Shenfu [2003] No. 64 document and explicitly entrusted the Shenzhen Federation of Industry to specifically organize and carry out activities to promote enterprises to build brands and create famous brands. So far, it has been continuously carried out for 18 sessions, and a total of more than 800 “Shenzhen Famous Brands” have been carried out. “Shenzhen Famous Brands”. According to statistical calculations, these enterprises only account for 0.4‰ of the total number of enterprises in the city, and their total sales account for 48.6% of the total sales of enterprises in the city. Many well-known brands rank first in domestic market segments and have made outstanding contributions to Shenzhen’s high quality and brand building.

This “Shenzhen Famous Brand” cultivation and evaluation activity requires, baseline;”>After preliminary review by the Shenzhen Famous Brand Evaluation Committee Secretariat, on-site review of the company’s internal management system, public voting, industry status evaluation, brand value assessment, review by the plenary meeting of the Evaluation Committee and other evaluation procedures, as well as on-site notarization by the Shenzhen Notary Office, a total of 59Companies with high market share, high integrity and high brand awareness are shortlisted for this year’s Shenzhen famous brand list. Beike Biology relies onExcellent comprehensive strength was successfully selected, and it was included in the list of “Shenzhen Famous Brands” together with Huawei, Mindray and other Shenzhen leading companies.

Founded in 2005, Beike Biotech has been deeply involved in the fields of stem cell basic research and clinical translational research for many years. It adheres to the core concept of “quality is the lifeline of an enterprise”, insists on R&D technological innovation, and strictly controls product quality. It has gained popularity and reputation with its rigorous and serious style, and has become a backbone that cannot be ignored in the field of stem cell clinical research in China.

Strength creates glory, quality creates brilliance! Beike Biotechnology has always insisted on speaking out with professionalism and quality, putting corporate innovation capabilities in the first place. As of November 2020, Has applied for 108 patents related to the field of cell technology, 56 of which have been authorized. Innovative and innovative baseline;”>The industrial development model of “comprehensive cell bank + regional cell preparation center + cell quality testing platform” provides an innovative public technology platform and infrastructure for the clinical transformation of cell therapy technology, and also lays a data foundation for the future development layout of artificial intelligence + biomedicine. In January 2020, North baseline;”>KeBiology’s research achievement “Key technological innovation and clinical application of allogeneic mesenchymal stem cells in the treatment of refractory lupus erythematosus” won the 2019 National Technology Invention Award.

While striving to improve its own strength and brand, Beike Biotech has also been actively fulfilling its social responsibilities. In the face of the sudden COVID-19 epidemic in 2020, Beike Biotech quickly responded to the national call and actively participated in technological research. In cooperation with Shenzhen Third People’s Hospital, we applied for the “Clinical Research on Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Severe Pneumonia Caused by Coronavirus” project and received approval from the Guangdong Provincial Department of Science and Technology for the “Guangdong Provincial Emergency Technology Research and Development Project for the Prevention and Control of Novel Coronavirus Infection”. The “Drug Research and Development of Mesenchymal Stem Cells for the Treatment of New Coronavirus Pneumonia” applied by Beike Biotech was approved by the National Ministry of Science and Technology as a key special project of “Science and Technology Assists the Economy 2020”.

If you want to wear a crown, you must bear its weight! Winning this honor is recognition of Beike Biotech’s long-standing recognition, and it is also a spur and encouragement for Beike Biotech’s future development. 2021 is a new starting point after the 40th anniversary of the establishment of the Shenzhen Special Economic Zone. As a “well-known brand in Shenzhen”, Beike Biotech will continue to drive development with innovation, take advantage of the policy advantages of the Guangdong-Hong Kong-Macao Greater Bay Area to accelerate the upgrading of corporate products and services, continue to deepen product technology research and development capabilities, further expand brand influence, use its own development to promote the development of the stem cell industry to higher quality, and make more contributions to the development of Shenzhen.